Second Heart Assist today announced data from a study highlighting the performance of its Whisper device against a ...

Since the COVID-19 pandemic, pulmonary embolisms are seen more frequently, according to the director of the Independence ...

Use of two high-risk cardiovascular devices—the Watchman (Boston Scientific) left atrial appendage occluder and the Impella (Abiomed) left ventricular assist device—is highest in the United States ...

Patients with cardiogenic shock supported by Impella CP in an Asian tertiary cardiac center ... non–ST‐segment–elevation myocardial infarction; PAC, pulmonary artery catheter; PAPi, pulmonary artery ...

The Impella RP Flex with SmartAssist System Catheter is used for up to 14 days in patients with acute right failure after left ventricular assist device implantation. There have been no reported ...

The Impella RP Flex with SmartAssist. [Image from Abiomed] The FDA today issued a notice informing customers of updated instructions for the Johnson & Johnson MedTech Abiomed Impella RP heart pump.

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...

Performing additional catheter ablations targeting diseased myocardium along with the standard approach of pulmonary vein isolation (PVI) to treat persistent atrial fibrillation (AFib) did not reduce ...

Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.

Impella CP is a percutaneously inserted left ventricular assist device indicated for temporary mechanical cardiac support during high risk percutaneous coronary interventions and for cardiogenic shock ...